Skip to main content
. 2017 Dec 20;18(12):2773. doi: 10.3390/ijms18122773
ALL acute lymphoblastic leukemia
ASCT allogenic stem cell transplantation
B-NHL B-cell non-Hodgkin lymphomas
CAR chimeric antigen receptor
CLL chronic lymphocytic leukemia
ORR objective response rates
OS overall survival
R/R relapsed or Refractory
NHL non-Hodgkin lymphoma
NSG NOD scid IL2Rgammanull